CergenX, leaders in neonatal neurotechnology, present Wave - an AI-powered device for rapid, expert-level brain assessments in newborns. With just 10 minutes of raw 2-channel EEG, Wave detects abnormal EEG activity, including seizures, to identify newborns at increased risk of neonatal encephalopathy. Powered by cutting-edge AI, the solution requires no specialist skills to assess brain health.
To learn more about our scalable AI platform, current trials, and see a demo of Wave, visit Booth 2132.